NCIt definition : A monoclonal antibody directed against the human cell surface glycoprotein ADP-ribosyl
cyclase 1 (CD38), with potential antineoplastic activity. Upon administration, lumrotatug
specifically targets and binds to CD38 expressed on tumor cells. This may trigger
antibody-dependent cellular cytotoxicity (ADCC), complement-dependent cytotoxicity
(CDC), antibody-dependent cellular phagocytosis (ADCP) and apoptosis, resulting in
cell lysis and depletion of CD38-expressing tumor cells. In addition, lumrotatug inhibits
the extracellular enzyme activity of CD38. CD38, a type II transmembrane glycoprotein,
is present on various immune cells and hematologic malignancies. It plays an important
role in the regulation of migration and receptor-mediated adhesion, as well as various
cell functions through its multiple ecto- and endo-enzymatic activities.;
UNII : GT2R696LEM;
CAS number : 2760318-99-6; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 2760318-99-6
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;
Semantic type(s)